|Day's Range||21.61 - 21.71|
|52 Week Range||13.00 - 22.17|
|PE Ratio (TTM)||-12.28|
|Earnings Date||Aug 2, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||21.00|
NEW YORK, NY / ACCESSWIRE / June 20, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Albany Molecular Research, Inc. (NASDAQ: AMRI) stock ...
BALA CYNWYD, PA / ACCESSWIRE / June 15, 2017 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Albany Molecular Research, Inc. ("Albany ...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Albany Molecular Research, Inc.